Pacureanu L - Search Results

1

Comprehensive investigation of selectivity landscape of glycogen synthase kinase-3 inhibitors.

Pacureanu L, Avram S, Crisan L. Pacureanu L, et al. J Biomol Struct Dyn. 2021 Apr;39(7):2318-2337. doi: 10.1080/07391102.2020.1747544. Epub 2020 Apr 7. J Biomol Struct Dyn. 2021. PMID: 32216607

2

PLS-DA - Docking Optimized Combined Energetic Terms (PLSDA-DOCET) protocol: a brief evaluation.

Avram S, Pacureanu LM, Seclaman E, Bora A, Kurunczi L. Avram S, et al. Among authors: pacureanu lm. J Chem Inf Model. 2011 Dec 27;51(12):3169-79. doi: 10.1021/ci2002268. Epub 2011 Dec 7. J Chem Inf Model. 2011. PMID: 22066983

3

Retrospective group fusion similarity search based on eROCE evaluation metric.

Avram SI, Crisan L, Bora A, Pacureanu LM, Avram S, Kurunczi L. Avram SI, et al. Among authors: pacureanu lm. Bioorg Med Chem. 2013 Mar 1;21(5):1268-78. doi: 10.1016/j.bmc.2012.12.041. Epub 2013 Jan 10. Bioorg Med Chem. 2013. PMID: 23375446

4

PLS and shape-based similarity analysis of maleimides--GSK-3 inhibitors.

Crisan L, Pacureanu L, Avram S, Bora A, Avram S, Kurunczi L. Crisan L, et al. Among authors: pacureanu l. J Enzyme Inhib Med Chem. 2014 Aug;29(4):599-610. doi: 10.3109/14756366.2013.833196. Epub 2013 Sep 19. J Enzyme Inhib Med Chem. 2014. PMID: 24047148 Free article.

5

ColBioS-FlavRC: a collection of bioselective flavonoids and related compounds filtered from high-throughput screening outcomes.

Avram SI, Pacureanu LM, Bora A, Crisan L, Avram S, Kurunczi L. Avram SI, et al. Among authors: pacureanu lm. J Chem Inf Model. 2014 Aug 25;54(8):2360-70. doi: 10.1021/ci5002668. Epub 2014 Jul 24. J Chem Inf Model. 2014. PMID: 25026200

6

Pharmacophore-based screening and drug repurposing exemplified on glycogen synthase kinase-3 inhibitors.

Crisan L, Avram S, Pacureanu L. Crisan L, et al. Among authors: pacureanu l. Mol Divers. 2017 May;21(2):385-405. doi: 10.1007/s11030-016-9724-5. Epub 2017 Jan 21. Mol Divers. 2017. PMID: 28108896

7

Partial Least Squares Discriminant Analysis and 3D Similarity Perspective Applied to Analyze Comprehensively the Selectivity of Glycogen Synthase Kinase 3 Inhibitors.

Crisan L, Avram S, Kurunczi L, Pacureanu L. Crisan L, et al. Among authors: pacureanu l. Mol Inform. 2020 Jun;39(6):e1900142. doi: 10.1002/minf.201900142. Epub 2020 Jan 16. Mol Inform. 2020. PMID: 31944600

8

Virtual screening and drug repurposing experiments to identify potential novel selective MAO-B inhibitors for Parkinson's disease treatment.

Crisan L, Istrate D, Bora A, Pacureanu L. Crisan L, et al. Among authors: pacureanu l. Mol Divers. 2021 Aug;25(3):1775-1794. doi: 10.1007/s11030-020-10155-6. Epub 2020 Nov 25. Mol Divers. 2021. PMID: 33237524

9

New Insights on the Activity and Selectivity of MAO-B Inhibitors through In Silico Methods.

Pacureanu L, Bora A, Crisan L. Pacureanu L, et al. Int J Mol Sci. 2023 May 31;24(11):9583. doi: 10.3390/ijms24119583. Int J Mol Sci. 2023. PMID: 37298535 Free PMC article.

10

QSAR modeling of the inhibition of glycogen synthase kinase-3.

Katritzky AR, Pacureanu LM, Dobchev DA, Fara DC, Duchowicz PR, Karelson M. Katritzky AR, et al. Bioorg Med Chem. 2006 Jul 15;14(14):4987-5002. doi: 10.1016/j.bmc.2006.03.009. Epub 2006 May 2. Bioorg Med Chem. 2006. PMID: 16650999

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters